Hopfield Jessica

Average Profitability
25.61%
Insider Buys Quantity
7
Insider Buys Sum
$2.56M
Insider Sells Quantity
1
Insider Sells Sum
$1.72M

Insider Activity of Hopfield Jessica

According to the SEC Form 4 filings, Hopfield Jessica, being in a position of

  1. director at Editas Medicine, Inc.,
    оver the last 12 months, has bought 45000 shares for $253,868, and sold 0 shares,
    over all time since 2018-05-17, has bought 67700 shares for $1.01M, and sold 0 shares.

The largest purchase of all time was on 2020-11-24 and amounted to 50000 shares of Maravai LifeSciences Holdings, Inc. for $1.35M.

The largest sale of all time was on 2024-09-11 and amounted to 7628 shares of Insulet Corporation for $1.72M.

Biography of Hopfield Jessica

No biography is available at this moment.

2024-09-11SaleInsulet Corporation
PODD
director
7,628
0.0108%
$225.26$1.72M+2.3%
2024-05-13PurchaseEditas Medicine, Inc.
EDIT
director
45,000
0.0541%
$5.64$253,868-29.51%
2021-03-03PurchaseEditas Medicine, Inc.
EDIT
director
5,800
0.0093%
$45.51$263,970-12.31%
2020-11-24PurchaseMaravai LifeSciences Holdings, Inc.
MRVI
director
50,000
0.127%
$27.00$1.35M+42.73%
2019-03-05PurchaseEditas Medicine, Inc.
EDIT
director
10,200
0.0212%
$23.94$244,188+3.98%
2018-05-17PurchaseEditas Medicine, Inc.
EDIT
director
6,700
0.014%
$37.28$249,780-26.91%
2017-05-11PurchaseInsulet Corporation
PODD
director
2,580
0.0044%
$38.68$99,783+73.41%
2016-03-02PurchaseInsulet Corporation
PODD
director
3,230
0.0057%
$30.91$99,839+18.27%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.